Celexa is in a class of drugs called selective serotonin reuptake inhibitors (SSRIs), a class of drugs that includes Paxil, Prozac and Zoloft. Selective serotonin reuptake inhibitors were linked in a 2006 study published in the New England Journal of Medicine to PPHN in infants exposed to the medications prior to birth. According to the study, exposure to certain antidepressants during the last three months of pregnancy resulted in up to six times the likelihood of babies being born with PPHN.
Persistent pulmonary hypertension of the newborn is a potentially fatal condition in which the baby's organs are deprived of oxygen. Up to 20 percent of babies born with PPHN do not survive their ordeal.
READ MORE CELEXA LEGAL NEWS
Meanwhile, a study published in the December 2009 issue of American Journal of Obstetrics & Gynecology suggested that women who began SSRI antidepressant therapy during their second or third trimester of pregnancy are up to five times more likely to experience preterm birth than women who either did not start any SSRI antidepressant therapy or started it during their first trimester.
Preterm birth carries its own risks, such as lower birth weight and respiratory distress.
Women who are pregnant and are currently taking Celexa should not discontinue their medication without first speaking to a doctor. Although there are reportedly risks of taking SSRIs such as Celexa during pregnancy, there are also risks to having untreated depression.